3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
18
Phase 2
9
Phase 1/2
9
Phase NA
4
Phase EARLY_PHASE1
2
Phase 3
2
Phase 4
1
Phase 2/3
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Breast Neoplasms
18
Neoplasms
16
Prostatic Neoplasms
12
Neoplasm Metastasis
10
Pain
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Lung Neoplasms
8
Polycystic Ovary Syndrome
7
Leiomyoma
6
Anemia
5
Skin Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia
4
Carcinoma, Renal Cell
4
Recurrence
3
Melanoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Keratosis, Actinic
3
Insulin Resistance
3
Carcinoma, Hepatocellular
3
Cancer Pain
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Interventions
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Terminated
×
Mesothelioma
×
Clear all
NCT03655821
2022-05-13
IMPROVE-II
Radboud University Medical Center
Phase 4
Terminated
81 enrolled